|
Unaudited Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
|
Nov. 30, 2011
|
Nov. 30, 2010
|
| Net income (loss) |
$ 50,407 |
$ (15,250) |
| Adjustments to reconcile net gain (loss) to net cash provided by (used in) operating activities: |
|
|
| Depreciation and amortization |
18,501 |
17,570 |
| (Benefit from) provision for deferred income taxes |
17,009 |
(18,378) |
| Stock-based compensation expense |
9,870 |
8,922 |
| (Earnings) losses from unconsolidated entities, net of taxes |
(6,953) |
(2,872) |
| Distributions from unconsolidated entities |
2,128 |
3,873 |
| Taxes paid upon net-share settlement of equity awards |
(50) |
(236) |
| Excess tax benefits from stock based compensation |
(112) |
(205) |
| Foreign currency transaction (gains) losses, net |
(27,359) |
11,412 |
| Other noncash Items |
995 |
4,197 |
| Changes in assets and liabilities, net of effects of acquisitions and consolidation of variable interest entities: |
|
|
| (Increase) decrease in accounts receivables |
36,658 |
(11,566) |
| (Increase) decrease in costs and estimated earnings in excess of billings on uncompleted contracts, including claims |
12,501 |
93,869 |
| (Increase) decrease in inventories |
(18,912) |
(8,818) |
| (Increase) decrease in other current assets |
25,972 |
(4,897) |
| Increase(decrease) in accounts payable |
(78,155) |
(109,335) |
| Increase (decrease) in accrued liabilities |
(44,724) |
(15,556) |
| Increase (decrease) in advanced billings and billings in excess of costs and estimated earnings on uncompleted contracts |
(128,628) |
(155,711) |
| Net change in other assets and liabilities |
(10,044) |
(8,988) |
| Net cash provided by (used in) operating activities |
(140,896) |
(211,969) |
| Cash flows from investing activities: |
|
|
| Purchases of property and equipment |
(24,307) |
(30,237) |
| Proceeds from sale of businesses and assets, net of cash surrendered |
1,599 |
715 |
| Investment(s) in notes receivable |
|
(10,100) |
| Cash deposited into restricted and escrowed cash |
(10,010) |
(474,623) |
| Cash withdrawn from restricted and escrowed cash |
17,608 |
416,824 |
| Purchases of short-term investments |
(75,104) |
(329,704) |
| Proceeds from sale and redemption of short-term investments |
58,003 |
279,562 |
| Proceeds from sale of restricted short term investments |
138,851 |
58,673 |
| Net cash provided by (used in) investing activities |
106,640 |
(88,890) |
| Cash flows from financing activities: |
|
|
| Purchase of treasury stock |
(21) |
(436) |
| Repayment of debt and capital leases |
(85) |
(3,429) |
| Payment of deferred financing costs |
(16) |
|
| Issuance of common stock |
519 |
2,464 |
| Excess tax benefits from exercise of stock options and vesting of restricted stock |
112 |
205 |
| Contributions received from noncontrolling interest |
3,075 |
600 |
| Distributions paid to noncontrolling interest |
(900) |
(1,385) |
| Net cash provided by (used in) financing activities |
2,684 |
(1,981) |
| Net effects on cash of deconsolidation of VIE(s) |
|
(12,800) |
| Effects of foreign exchange rate changes on cash |
(5,462) |
2,733 |
| Net change in cash and cash equivalents |
(37,034) |
(312,907) |
| Cash and cash equivalents — beginning of year |
674,080 |
912,736 |
| Cash and cash equivalents — end of year |
$ 637,046 |
$ 599,829 |